|
Disclosure Policy
The American Society of Anesthesiologists remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of the American Society of Anesthesiologists to eliminate all situations of potential conflict of interest, but rather to enable those who are working with the American Society of Anesthesiologists to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the educational activity course director/chair to ensure that such situations are properly evaluated and, if necessary, resolved. The American Society of Anesthesiologists educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all American Society of Anesthesiologists CME activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.
Disclosures
|
Name
|
Role
|
Interest
|
Ineligible Company
|
|
Brendan Carvalho
|
Faculty
Moderator
|
Consultant
|
Rivanna Medical, LLC
|
|
Consultant
|
Stryker Corporation
|
|
Stock Option
|
Flat Medical
|
|
Michaela Farber
|
Faculty
Abstract Reviewer
|
Consultant
|
HemoSonics LLC
|
|
Consultant
|
Octapharma USA, Inc.
|
|
Grant / Contract
|
Flat Medical
|
|
Ashraf Habib
|
Planner/Faculty
Planning Subcommittee
Abstract Reviewer
|
Grant / Contract
|
Haisco USA
|
|
Advisory Board
|
Heron Therapeutics, Inc.
|
|
Grant / Contract
|
Heron Therapeutics, Inc.
|
|
Advisory Board
|
Merck
|
|
Grant / Contract
|
Pacira Pharmaceuticals Inc
|
|
Ashwini Joshi
|
Abstracts/Planning Subcommittee
|
Stock
|
CVS Caremark Corporation
|
|
Tom Klumpner
|
Planner/Abstract Reviewer
|
Grant / Contact
|
BioIntellisense
|
|
Ruth Landau
|
Faculty/Planning Subcommittee
|
Consultant - Scientific Advisory Board
|
Pacira Pharmaceuticals Inc
|
|
Elizabeth Lange
|
Abstracts/Abstract Reviewer
|
Consultant
|
Octapharama USA, Inc.
|
|
Rebecca Minehart
|
Planner/Abstract/
Faculty
|
Consultant
|
Rivanna Medical, LLC
|
|
Clemens Ortner
|
Faculty
|
Consultant
|
Sonologi Inc.
|
|
Maria Sheikh
|
Faculty/Abstract Reviewer
|
Stock
|
Butterfly Network, Inc.
|
|
Shashank Shettar
|
Abstracts/Abstract Reviewer
|
Consultant
|
Rivanna Medical, LLC
|
|
Brandon Togioka
|
Planner/Faculty/
Planning Subcommittee
|
Grant / Contract
|
B. Braun Medical
|
|
Grant / Contract
|
Haisco Pharmaceutical Group
|
|
Grant / Contract
|
Merck
|
|
Grant / Contract
|
Georgia-Pacific
|
|
Paloma Toledo
|
Faculty/Abstracts
|
Speaker
|
Pacira Pharmaceuticals Inc
|
|
Richard Smiley
|
Abstract Reviewer Subcommittee
|
Stock
|
AbbVie
|
|
Stock
|
Amgen
|
|
Grant / Contract
|
Biogen
|
|
Grant / Contract
|
Ionis Pharmaceuticals
|
|
Stock
|
Merck
|
|
Grant / Contract
|
Pacira Pharmaceuticals Inc
|
|
Stock
|
Pfizer Pharmaceuticals LLC
|
|
Grace Lim
|
Faculty Judge
|
Consultant - Advisory Board
|
Huron Therapeutics
|
|
Consultant - Chair, advisory board
|
Octapharma USA, Inc.
|
|
Jeremy Collins
|
Abstract Reviewer
|
Consultant
|
Fisher & Paykel Healthcare Ltd
|
|
Sangeeta Kumaraswami
|
Abstract Reviewer
|
Stock
|
Eli LIlly
|
|
Stock
|
Johnson and Johnson
|
|
Stock
|
Procter and Gamble
|
All of the relevant financial relationships listed for these individuals have been mitigated.
All other planners, faculty, reviewers, and staff have disclosed no relevant financial relationships with ineligible companies.
Disclaimer
The information provided at this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
|
